Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials (Q39677391)
Jump to navigation
Jump to search
scientific article published on 6 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials |
scientific article published on 6 December 2011 |
Statements
1 reference
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials (English)
1 reference
Maria Rosa Strada
1 reference
Raffaella Palumbo
1 reference
Antonio Bernardo
1 reference
Alberto Riccardi
1 reference
Cristina Teragni
1 reference
Guido Poggi
1 reference
Mara Frascaroli
1 reference
Alessio Amatu
1 reference
Benedetta Montagna
1 reference
Federico Sottotetti
1 reference
Barbara Tagliaferri
1 reference
Giovanni Bernardo
1 reference
6 December 2011
1 reference
1 reference
Identifiers
1 reference